Occupational asthma due to isocyanates: Study of 21 patients;Asma ocupacional por isocianatos: Estudio de 21 pacientes

Medicina Clinica

Volumn 113, Issue 17, 1999, Pages 659-662

  Orriols, Ramon ^a   Drobnic, María Estrella ^b   Muñoz, Xavier ^b   Rodrigo, María José ^b   Morell, Ferran ^b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b NONE

Author keywords

Isocyanates; Occupational asthma

Indexed keywords

IMMUNOGLOBULIN E; ISOCYANIC ACID DERIVATIVE;

ADULT; ARTICLE; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PROVOCATION TEST;

ADULT; ASTHMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOCYANATES; MALE; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RESPIRATORY FUNCTION TESTS; SKIN TESTS;

EID: 0033589820     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mapp CE, Chang-Yeung M. Occupational agents. En: Barnes P, Grunstein MM, editores. Filadelfia: Lippincott-Raven Publishers. Asthma 1997; 85: 1.217-1.244.
2. Sastre J, Ibáñez MD. Asma inducido por isocianatos. Arch Bronconeumol 1988; 24: 245-249.
3. Fuchs S, Valade P. Étude clinique et experimentale sur quelque cas d'intoxication par les Dermodur (diisocyanate de toluene 1-2-4 et 1-2-6). Arch Mal Prof Med Trav Sec Soc 1951; 12: 191-196.
4. Scheel LD, Killens R, Josepphson A. Immunochemical aspects of toluene diisocyanate (TDI) toxicity. Am Ind Hyg Assoc J 1964; 2: 179-184.
5. Mapp CE, Boscheto P, Dai Vecchio L, Maestrelli P, Fabbri LM. Occupational asthma due to isocyanates. Eur Respir J 1988; 1: 273-279.
6. Brooks SM. Bronchial asthma of occupational origin. Seend J Mork Environ Health 1977; 3: 53-72
7. NIOSH Criteria for Recomended Standar. Occupational exposure to diisocyanate. Washington, DC: US Dep. of Health, education and Welfare. NIOSH. Publication n.o 78, 1978; 215.
8. Butcher BT, Jones RN, O'Neil CE, Glinmayer HW, Diem JE. Longitudinal study of workers employed in the manufacture of toluene diisocyanate. Am Rev Respir Dis 1977; 111: 411-421.
9. Avary SB, Stetson DM, Pan PM, Mathews KP. Immunological investigation of individuals with tolueno diisocyanate asthma. Clin. Exp Inmunol 1969, 4: 585-596.
10. Kogevinas M, Antó JM, Soriano JB, Tobías A, Burney P. The risk of asthma attribuible to occupational exposures. A population based study in Spain. Am J Respir Crit Care Med 1996; 154: 137-143.
11. Adams WG. Long-term effects on the health of men engaged in the manufacture of toluene diisocianate. Br J Ind Med 1975; 32: 72-78.
12. Lam S, Wong R. Chang Yeung M. Nonspecific bronchial reactivity in occupational asthma. J Allergy Clin Inmunol 1979; 63: 28-34.
13. Moller DR, McKay RT, Bernstein IL, Brooks S. Long-term follow up of workers with TDI asthma. Am Rev Respir Dis 1984; 129 (Supl A): 159.
14. Moller DR, Brooks SM, McKay RT. Chronic asthma due to isocyanate. Chest 1986; 90: 494-499.
15. Paggiaro PL, Vagaggani B, Bacci E, Bancalari L. Prognosis of occupational asthma. Eur Respir J 1994; 7: 761-767.
16. Paggiaro PL, Loi AM, Rossi O, Ferrante B, Pardi F, Rosselli MG et al. Follow up study of patients with respiratory disease due to TDI. Clin Allergy 1984; 14: 463-469.
17. McKay RT, Brooks SM. Toluene diisocyanate: biochemical and physiological studies. Am Rev Respir Dis 1981; 123: 132.
18. Quanjer Ph, Tamarely GI, Cotes JE. Lung Volumen and forced ventilatory flows. Eur Respir J 1993; 6 (Supl 16): 5-40.
19. Yan K, Salome C, Woodcok AJ. Rapid method for measurement of bronchial responsiveness. Thorax 1983; 38: 55-61.
20. Moscato G, Godnic-Cvar J, Maestrelli P, Malo JL, Burge PS, Coifman R. Statement on self monitoring of peak expiratory flows in the investigation of occupational asthma. Eur Respir J 1995; 8: 1.605-1.610.
21. Perris B, Largier F, L'Acheveque J. Occupational asthma: validity of monitoring of peak expiratory flow rates and non allergic bronchial responsiveness as compared to specific inhalation challenge. Eur Respir J 1992; 5: 40-48.
22. 1 in the diagnosis of occupational asthma. Am J Respir Crit Care Med 1998; 158: 827-832.
23. Côté J, Kennedy S, Chang-Yeung M. Quantitative versus qualitative analysis of peak expiratory flow in occupational asthma. Thorax 1993; 48:48-51.
24. Pepys J, Hutchcroft BJ. Bronchial provocation test in etiology diagnosis and analysis of asthma. Am Rev Respir Dis 1975; 112: 829-859.
25. a ed.). Oxford: Butterworth-Heinemann, 1994; 21: 710-729.
26. Meredith SK, Taylor VM, McDonald JC. Occupational respitatory disease in the United Kingdom 1989. A report by the British Thoracic Society and the Society of Occupational Medicine by the SWORD Project Group. Br J Med 1991; 48: 292-298.
27. Karol MH, Ioset HH, Alarie YC. Tolyl specific IgE antibodies in workers hypersensitivity to toluene diisocianate. Am Ind Hyg Assoc J 1978; 39: 454-458.
28. Was V, Belin L. Immunologic specifity of isocyanate induced IgE antibodies in serum from 10 sensiticed workers. J Allergy Clin Immunol 1989; 83: 126-135.
29. Tee RD, Cullinan P, Welch J, Burge PS, Newman Taylor AJ. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol 1998; 101: 5: 709-715.
30. Mapp C, Arone P, Marzo N, Fabri L. Persistent asthma due to isocyanates A follow up study of subjects with occupational asthma due to toluene diisocyanate. Am Rev Respir Dis 1988; 137: 1.326-1.329.